Stocks
Burning Rock Biotech LimitedBNR
NASDAQHealthcareBiotechnology$11.82
Price as of · delayed, not real-time
A molecular profiling company focused on precision oncology, offering genomic testing services and data solutions for cancer diagnosis and treatment. It provides a comprehensive suite of liquid biopsy and tissue-based tests, positioning itself as a key player in China's growing precision medicine market. Investors track BNR due to its revenue growth potential and the expansion of its clinical adoption.
52W Range: $6.79-$41.72
Congressional Interest in Burning Rock Biotech Limited (BNR)
No congressional trades have been disclosed for Burning Rock Biotech Limited (BNR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BNR?
No congressional trades found for this stock.